The Scientific Program will be realized based on the Central European Time (CET) + 1 hr
ATHENA 2023 Scientific Program
Tuesday 21-11-2023
| 14.00-20.00 | Infections' Preventionists Gate |
|
14.00-15.15 |
Catheter Related Bloodstream Infections:
Yes we can reduce the burden Chairs: T. Katsoulas - O. Dalingarou |
Speaker |
| 14.00-14.15 | Impact of CRBSIs | K. Arvaniti |
| 14.15-14.30 | Surveillance methods and definitions for CRBSIs | C. Triantafyllou |
| 14.30-14.45 | Risk factors for the onset of CRBSIs | E. Douka |
| 14.45-15.00 | Ultrasound guidance use for catheter insertion | T. Katsoulas |
| 15.00-15.15 | Q & A / Discussion |
|
15.15-15.45 Break |
|
15.45-17.00 |
Management of Central Venous Catheters
for the prevention of CRBSIs Chairs: G. Saroglou - P. Myrianthefs |
Speaker |
| 15.45-16.00 | Recommended strategies to prevent CRBSIs during the insertion of Central Venous Catheters: What’s new? | D. Topka |
| 16.00-16.15 | Care bundles on the prevention of CRBSIs | P. Varda |
| 16.15-16.30 | Additional approaches for the prevention of CRBSIs | F. Sourri |
| 16.30-16.45 | Unresolved issues on CRBSIs prevention | I. Koutsodimitropoulos |
| 16.45-17.00 | Q & A / Discussion |
|
17.00-17.30 Break |
|
17.30-18.45 |
New approaches to infection prevention Chairs: D. Hatzigeorgiou - D. Kaitelidou |
Speaker |
| 17.30-17.45 | The role of new technologies in the prevention of CRBSIs | P. Stamataki |
| 17.45-18.00 | Development of integrated infection prevention programmes | M. Tseroni |
| 18.00-18.15 | Quality audit tools for infection prevention | A. Karaiskou |
| 18.15-18.30 | The financial benefit of infection prevention | K. Athanasakis |
| 18.30-18.45 | Q & A / Discussion |
|
18.45-20.00 |
CRBSI prevention: Addressing clinical challenges with catheter maintenance – critical care,
oncology, haemodialysis |
Speaker |
| 18.45-19.15 | Theoretical part | A. M. Serra |
| 19.15-19.25 | Q & A / Discussion | |
| 19.25-20.00 | Practical part | M. Kosi |
Wednesday 22-11-2023
|
09.00-09.15 |
Opening lecture Chair: G. Dimopoulos |
Speaker |
| COVID-19: 3 years after | M.A. Dimopoulos |
|
09.15-11.00 |
Burning issues in the ICU Chairs: D. Kofteridis - G. Vlachogianni |
Speaker |
| 09.15-09.30 | Severe legionellosis | K. Akinosoglou |
| 09.30-09.45 | Cardiac arrest and infections | S. Mentzelopoulos |
| 09.45-10.00 | IAP increases VAP incidence: show me the data | D. Makris |
| 10.00-10.15 | Prone position - A life saving technique for COVID-19 VAP |
D. Georgopoulos |
| 10.15-10.30 | New antigungal agents | O. Cornely |
| 10.30-10.45 | PCP Pneumonia | D.-R. Giacobbe |
| 10.45-11.00 | Q & A / Discussion |
|
11.00-12.00 |
Satellite Symposium MSD Chair: G. Dimopoulos |
Speaker |
| 11.00-11.05 | Introductory Lecture | G. Dimopoulos |
| 11.05-11.30 | Ceftolozane/Tazobactam: A potent Cephalosporin/β- Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli | N. Sipsas |
| 11.30-11.55 | Imipenem/cilastatin/relebactam: A new carbapenem/ β-lactamase inhibitor combination for the treatment of complicated Gram-negative infections | E. Christaki |
| 11.55-12.00 | Q & A / Discussion |
12.00-13.00 Break
|
13.00-14.45 |
Burning issues in the ICU Chairs: Ch. Gogos - E. Antoniadou |
Speaker |
| 13.00-13.15 | Invasive Pulmonary Aspergillosis | J. Garnacho-Montero |
| 13.15-13.30 | Chronic pulmonary Aspergillosis | O. Cornely |
| 13.30-13.45 | Aspergillus Tracheobronchitis | H. Sambatakou |
| 13.45-14.00 | Osteoarticular Mycoses | M. Gamaletsou |
| 14.00-14.15 | Mucormycosis | D. Karapiperis |
| 14.15-14.45 | Q & A / Discussion |
14.45-15.00 Break
|
15.00-16.00 |
Challenges in implementing Antimicrobial
Stewardship (AMS) in Greek hospitals:
the pharmacists’ perspective Chairs: G. Dimopoulos - A. Markogiannakis |
Speaker |
| 15.00-15.15 | Multi-Drug Resistant (MDR) microbial infections and AMS: the hospital pharmacy perspective | D. Gennimata |
| 15.15-15.30 | Optimizing antimicrobial therapy in critically ill patients | K. Ioannidis |
| 15.30-15.45 | Implementing an AMS program in a tertiary hospital | A. Markogiannakis |
| 15.45-16.00 | Q & A / Discussion |
16.00-16.30 Break
|
16.30-17.30 |
SATELLITE SYMPOSIUM 3M Chair: G. Dimopoulos |
Speaker |
| 16.30-17.15 | Prophylactic Negative Pressure devices in prevention and management of surgical infections and complications | K. Toutouzas |
| 17.15-17.30 | Q & A / Discussion |
Thursday 23-11-2023
|
09.00-11.00 |
Burning issues in the ICU Chairs: M. Marangos - N. Kapravelos |
Speaker |
| 09.00-09.15 | Infections due to MRSA | D. Koulenti |
| 09.15-09.30 | MDR: antibiotic combinations | J. Garnacho-Montero |
| 09.30-09.45 | Antimicrobial stewardship | M. Akova |
| 09.45-10.00 | Bacterial infections: Fast Diagnosis | M. Antonelli |
| 10.00-10.15 | When to give antifungal therapy in abdominal sepsis | C. Eckmann |
| 10.15-10.30 | Infections in hematology oncology ICU patients | E. Terpos |
| 10.30-11.00 | Q & A / Discussion |
|
11.00-12.00 |
Burning issues in the ICU Chair: V. Papaioannou |
Speaker |
| 11.00-11.15 | Eravacycline | G. Dimopoulos |
| 11.15-11.30 | Angiotensin II | S. Mentzelopoulos |
| 11.30-11.45 | Heart rate variability, autonomic disfunction and immune response in sepsis | V. Papaioannou |
| 11.45-12.00 | Q & A / Discussion |
|
12.00-13.00 |
Satellite Symposium SANTAIR Innovation in Sepsis Management Chair: G. Dimopoulos |
Speaker |
| 12.00-12.45 | Fibrinolysis Resistance in Sepsis - Pathophysiology, Diagnostics and Therapeutic Approaches | A. Calatzis |
| 12.45-13.00 | Q & A / Discussion |
13.00-14.00 Break
|
14.00-15.30 |
Challenges in the ICU I Chairs: E. Mouloudi - A. Komnos |
Speaker |
| 14.00-14.15 | Monkey pox | M. Akova |
| 14.15-14.30 | Τrained immunity | T. Calandra |
| 14.30-14.45 | Precision Medicine in the ICU | E. Giamarellos |
| 14.45-15.00 | Necrotizing Fasciitis | C. Eckmann | 15.00-15.30 | Q & A / Discussion |
15.30-16.00 Break
|
16.00-17.00 |
Satellite Symposium ELPEN IV Fosfomycin in Difficult-to-Treat Infections Chair: Ch. Gogos |
Speaker |
| 16.00-16.25 | Gram(-) Difficult-to-Treat Infections | E. Giamarellos-Bourboulis |
| 16.25-16.50 | Gram(+) Difficult-to-Treat Infections | P. Panagopoulos |
| 16.50-17.00 | Q & A / Discussion |
17.00-17.30 Break
|
17.30-18.30 |
Satellite Symposium PFIZER Chairs: G. Daikos - A. Kotanidou |
Speaker |
| 17.30-17.55 | The role of Ceftazidime-avibactam in the treatment of MDR Gram-negative infections | K. Akinosoglou |
| 17.55-18.20 | Treating aspergillosis in ICU: The role of Isavouconazole | G. Dimopoulos |
| 18.20-18.30 | Q & A / Discussion |
Friday 24-11-2023
|
09.15-11.00 |
The European Perspective of Future Training in Intensive Care Medicine Chairs: G. Dimopoulos - S. Mentzelopoulos |
Speaker |
| 09.15-09.30 | Inhomogeneities and major challenges in training | M. Antonelli |
| 09.30-09.45 | Training in the ICU environment: Ethical dilemmas,
complex communication and burnout |
S. Mentzelopoulos |
| 09.45-10.00 | Emerging infections – current obstacles and perspectives |
S. Blot |
| 10.00-10.15 | Continuing medical education (CME) - Mentorship | I. Siempos |
| 10.15-10.30 | NV-HAP vs V- HAP vs VAP: differences | E. Magira |
| 10.30-11.00 | Q & A / Discussion |
|
11.00-12.00 |
Satellite Symposium Menarini Hellas AMS and the management of CRE-KPC infections in the era of new BLIs: The role of meropenemvaborbactam Chair: Ch. Gogos |
Speaker |
| 11.00-11.25 | Antimicrobial stewardship for CPE infections: challenges and opportunities | E. Douka |
| 11.25-11.50 | The role of meropenem-vaborbactam in the era of new BL/ BLIs | M. Gamaletsou |
| 11.50-12.00 | Q & A / Discussion |
12.00-13.00 Break
|
13.00-14.45 |
Challenges in the ICU II Chairs: E. Zakynthinos - V. Papaioannou |
Speaker |
| 13.00-13.15 | Candida auris | S. Blot |
| 13.15-13.30 | Fungal sepsis | T. Calandra |
| 13.30-13.45 | Infections in transplant patients | N. Sipsas |
| 13.45-14.00 | New antiviral agents against COVID-19 | M. Bassetti |
| 14.00-14.15 | Novel antibiotics for severe bacterial infections | G. Daikos |
| 14.15-14.45 | Q & A / Discussion |
14.45-15.00 Break
|
15.00-16.00 |
Challenges in the ICU III Chairs: N. Sipsas - Ch. Gogos |
Speaker |
| 15.00-15.15 | Infections - Fast Diagnosis | J. Meletiadis |
| 15.15-15.30 | Greek CDC: Antimicrobial stewardship in Greece | Th. Zaoutis |
| 15.30-15.45 | The financial benefit of infection prevention in critical care |
I. Yfantopoulos |
| 15.45-16.00 | Q & A / Discussion |
16.00 End of Meeting